title: Response to Re: Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use.
authors.affiliation: Alfred Health, Melbourne, Victoria, Australia.
authors.forename: Olivia R
authors.initials: OR
authors.lastname: Leahy
authors.affiliation: Cabrini Health, Melbourne, Victoria, Australia.|Eastern Health, Melbourne, Victoria, Australia.|Monash University, Melbourne, Victoria, Australia.
authors.forename: Mary
authors.initials: M
authors.lastname: O'Reilly
authors.affiliation: Monash Health, Melbourne, Victoria, Australia and.
authors.forename: David R
authors.initials: DR
authors.lastname: Dyer
authors.affiliation: Eastern Health, Melbourne, Victoria, Australia.
authors.forename: David
authors.initials: D
authors.lastname: Phillips
authors.affiliation: Alfred Health, Melbourne, Victoria, Australia.|Cabrini Health, Melbourne, Victoria, Australia.|Monash University, Melbourne, Victoria, Australia.|Epworth Healthcare, Melbourne, Victoria, Australia.
authors.forename: Jeremy P
authors.initials: JP
authors.lastname: Grummet
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001706:Biopsy; D001707:Biopsy, Needle; D015780:Carbapenems; D006801:Humans; D011467:Prostate; D011471:Prostatic Neoplasms; D018805:Sepsis
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems